Tag Archives: Bayer

#FierceMadness pharma ad contest narrows: Pfizer, Bayer, Novartis, ViiV and Biohaven among the Elite Eight still standing

FierceMadess voters have spoken—and now, just an Elite Eight pharma advertisers are still in the running for the 2021 title. Pfizer, Bayer, Novartis, Roche, Johnson & Johnson and GlaxoSmithKline’s ViiV Healthcare are among the Big Pharma contenders still playing in the DTC ad campaign contest, while Evofem Biosciences and Biohaven Pharmaceuticals are the smaller upstarts looking for… Read More »

Bayer floats animal health merger with Lilly spinoff Elanco: report

Bayer’s for-sale animal health unit has been stirring up interest among private equity players—but the German pharma may have another buyer in mind. The company has approached Elanco, spun off by Eli Lilly last year, about a potential tie-up between the two, Reuters reports, citing three unnamed sources. Elanco currently holds the animal health market’s… Read More »

Bayer to pay $2 billion after losing suit that claims weedkiller Roundup causes cancer

Bottles of Roundup weed killer move along the production line at the herbicide manufacturing facility operated by Monsanto. Jasper Juinen | Bloomberg | Getty Images Bayer AG on Monday was ordered by a Northern California jury to pay more than $ 2 billion to a couple who say they were diagnosed with cancer after using… Read More »

With safety data, Bayer could challenge Erleada, Xtandi in prostate cancer: analyst

For years, Johnson & Johnson and the Pfizer-Astellas team have been the only players in their class of prostate-cancer fighters. But Bayer is waiting in the wings, and stellar new safety data could make it a threat. The German drugmaker trumpeted phase 3 data Thursday on its androgen receptor antagonist candidate, darolutamide, showing that the drug… Read More »